BM
NKTR icon

Bridger Management’s Nektar Therapeutics NKTR Stock Holding History

Bridger Management’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-72,240
Closed -$38.6M – 32
2019
Q2 		$38.6M Sell
72,240
-10,326
-13% -$5.18M 3.03% 15
2019
Q1 		$41.6M Buy
82,566
+6,938
+9% +$4.11M 3.29% 14
2018
Q4 		$37.3M Hold
75,628
– – 3.11% 16
2018
Q3 		$69.2M Hold
75,628
– – 4% 9
2018
Q2 		$55.4M Buy
75,628
+31,062
+70% +$35.8M 3% 15
2018
Q1 		$71M Sell
44,566
-46,579
-51% -$60M 4.31% 6
2017
Q4 		$81.6M Sell
91,145
-60,499
-40% -$35.8M 5.39% 4
2017
Q3 		$54.6M Sell
151,644
-35,762
-19% -$11.2M 3.27% 14
2017
Q2 		$55M Sell
187,406
-8,411
-4% -$2.43M 3.14% 11
2017
Q1 		$68.9M Sell
195,817
-67,162
-26% -$15.1M 3.93% 7
2016
Q4 		$48.4M Buy
262,979
+74,137
+39% +$15.1M 3.37% 16
2016
Q3 		$48.7M Sell
188,842
-51,062
-21% -$13.1M 3.28% 13
2016
Q2 		$51.2M Buy
239,904
+5,437
+2% +$1.22M 3.31% 14
2016
Q1 		$48.4M Buy
234,467
+130,210
+125% +$25M 3.34% 15
2015
Q4 		$26.4M Buy
+104,257
New +$21.4M 0.87% 24

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bridger Management's NKTR Position: Q3 2019 in Review

Bridger Management sold out of Nektar Therapeutics (NKTR) in Q3 2019, closing a stake of 72,240 shares — an estimated $38.6M sold.

Bridger Management first reported a position in NKTR in Q4 2015 and held it in 15 quarters. The position peaked at $81.6M in Q4 2017. 288 funds tracked by Wall St. Rank hold NKTR as of Q3 2019.

  • Bridger Management reported no remaining Nektar Therapeutics position as of Q3 2019 after selling out during the quarter.
  • Bridger Management sold 72,240 Nektar Therapeutics shares in Q3 2019, an estimated $38.6M.
  • Bridger Management first reported a position in Nektar Therapeutics in Q4 2015 and held it in 15 quarters.
  • Bridger Management's Nektar Therapeutics position peaked at $81.6M in Q4 2017.
  • 288 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2019.

Based on Bridger Management's 13F filing for Q3 2019, filed 14 Nov 2019.